EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment choice in relation to the patients risk profile in lower urinary tract symptoms/benign prostatic hyperplasia A systematic analysis of expert opinion



Treatment choice in relation to the patients risk profile in lower urinary tract symptoms/benign prostatic hyperplasia A systematic analysis of expert opinion



Journal of Urology 171(4 Supplement): 357, April




(PDF 0-2 workdays service: $29.90)

Accession: 035980100

Download citation: RISBibTeXText



Related references

Integrating risk profiles in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia A systematic analysis of expert opinion. European Urology Supplements 3(2): 61, February, 2004

Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia; a systematic analysis of expert opinion. European Urology Supplements 3(2): 39, February, 2004

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression. Bju International 95 Suppl 4: 6-11, 2005

Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. European Urology Focus: -, 2018

Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?. Current Opinion in Urology 21(1): 42-48, 2011

Systematic review and meta-analysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia. Clinical Radiology (): -, 2016

Men's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment. Patient Preference and Adherence 10(): 2407-2417, 2016

General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. Current Medical Research and Opinion 31(2): 353-365, 2015

Men's Preferences For The Treatment Of Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph): A Discrete Choice Experiment (Dce). Value in Health 17(7): A472-A472, 2014

Integrating the patient risk profile in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). European Urology Supplements 3(4): 1-6, 2004

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile. Bju International 95 Suppl 4: 1-5, 2005

Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. World Journal of Urology: -, 2018

The predictor analysis of response to routine treatment in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Neuro Endocrinology Letters 35(2): 116-122, 2014

The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis. Journal of Sexual Medicine 11(6): 1539-1545, 2014

Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries. Bju International 101(9): 1111-1118, 2008